United States · FDA National Drug Code directory
tizanidine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 76420-886_2a395a10-4c73-4213-e063-6394a90abb25
- Product NDC
- 76420-886
- Form
- TABLET
- Composition / generic term
- tizanidine
- Labeler
- Asclemed USA, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20210304
- Source listing expiry
- 20261231
Source-listed ingredients
- TIZANIDINE HYDROCHLORIDE — 4 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1000 TABLET in 1 BOTTLE (76420-886-00) · 76420-886-00
- 100 TABLET in 1 BOTTLE (76420-886-01) · 76420-886-01
- 300 TABLET in 1 BOTTLE (76420-886-03) · 76420-886-03
- 10 TABLET in 1 BLISTER PACK (76420-886-11) · 76420-886-11
- 15 TABLET in 1 BOTTLE (76420-886-15) · 76420-886-15
- 150 TABLET in 1 BOTTLE (76420-886-21) · 76420-886-21
- 30 TABLET in 1 BOTTLE (76420-886-30) · 76420-886-30
- 60 TABLET in 1 BOTTLE (76420-886-60) · 76420-886-60
- 10 TABLET in 1 BOTTLE (76420-886-88) · 76420-886-88
- 90 TABLET in 1 BOTTLE (76420-886-90) · 76420-886-90
- 10 BLISTER PACK in 1 CARTON (76420-886-99) / 10 TABLET in 1 BLISTER PACK · 76420-886-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →